Literature DB >> 32439744

Fatal Clostridium septicum febrile neutropenia during adjuvant chemotherapy for early breast cancer.

João Moreira-Pinto1, José Luís Passos-Coelho2, Fabio Lopes2, Monica Ataíde3, Paulo Oliveira4.   

Abstract

We report the case of a 76-year-old female patient with early breast cancer (hormone receptor-positive erbb2 amplified) that had started adjuvant chemotherapy with docetaxel, carboplatin and trastuzumab (TCH). Eight days after the first cycle of TCH chemotherapy, the patient was diagnosed with grade 1 oral mucositis, treated conservatively. The next day she started with nausea, vomiting, chills and fever, followed by a generalised tonicoclonic seizure. She presented to the emergency department with fever, hypotension and mild abdominal tenderness. Grade 4 neutropenia (370 μL/mL) and severe metabolic acidosis were documented. An abdominal CT scan documented extensive ischaemic bowel changes, with gas in portal and mesenteric veins, and pneumoretroperitoneum. Despite broad spectrum antibiotics and fluid resuscitation, she died 4 hours after admitted to hospital. Blood cultures collected on hospital admission eventually grew Clostridium septicum bacteria, an extremely rare infection in patient with breast cancer. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  breast cancer; hepatitis and other GI infections; malignant disease and immunosuppression

Mesh:

Year:  2020        PMID: 32439744      PMCID: PMC7247384          DOI: 10.1136/bcr-2019-233778

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

1.  2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours.

Authors:  M S Aapro; J Bohlius; D A Cameron; Lissandra Dal Lago; J Peter Donnelly; N Kearney; G H Lyman; R Pettengell; V C Tjan-Heijnen; J Walewski; Damien C Weber; C Zielinski
Journal:  Eur J Cancer       Date:  2010-11-20       Impact factor: 9.162

2.  Neutropenic enterocolitis associated with docetaxel therapy in a patient with breast cancer.

Authors:  Kenneth V I Rolston
Journal:  Clin Adv Hematol Oncol       Date:  2009-08

3.  Lethal human neutropenic entercolitis caused by Clostridium chauvoei in the United States: tip of the iceberg?

Authors:  Jill E Weatherhead; David J Tweardy
Journal:  J Infect       Date:  2011-09-16       Impact factor: 6.072

Review 4.  Clostridium septicum and malignancy.

Authors:  S S Chew; D Z Lubowski
Journal:  ANZ J Surg       Date:  2001-11       Impact factor: 1.872

5.  Dose-finding study of epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer.

Authors:  O Pagani; C Sessa; G Martinelli; D Crivellari; A Buonadonna; B Thürlimann; D Hess; M Borner; J Bauer; G Zampino; M Zimatore; R Graffeo; A Riva; A Goldhirsch
Journal:  Ann Oncol       Date:  1999-05       Impact factor: 32.976

6.  Adjuvant trastuzumab in HER2-positive breast cancer.

Authors:  Dennis Slamon; Wolfgang Eiermann; Nicholas Robert; Tadeusz Pienkowski; Miguel Martin; Michael Press; John Mackey; John Glaspy; Arlene Chan; Marek Pawlicki; Tamas Pinter; Vicente Valero; Mei-Ching Liu; Guido Sauter; Gunter von Minckwitz; Frances Visco; Valerie Bee; Marc Buyse; Belguendouz Bendahmane; Isabelle Tabah-Fisch; Mary-Ann Lindsay; Alessandro Riva; John Crown
Journal:  N Engl J Med       Date:  2011-10-06       Impact factor: 91.245

7.  The alpha-toxin of Clostridium septicum is essential for virulence.

Authors:  Catherine L Kennedy; Efrosinia O Krejany; Lauren F Young; Jennifer R O'Connor; Milena M Awad; Richard L Boyd; John J Emmins; Dena Lyras; Julian I Rood
Journal:  Mol Microbiol       Date:  2005-09       Impact factor: 3.501

Review 8.  Malignancy, mortality, and medicosurgical management of Clostridium septicum infection.

Authors:  C M Larson; M P Bubrick; D M Jacobs; M A West
Journal:  Surgery       Date:  1995-10       Impact factor: 3.982

9.  Fulminating septic shock from Clostridium perfringens in an early breast cancer patient with severe myalgia after docetaxel treatment.

Authors:  Alessandro Marco Minisini; Jessica Menis; Alessandro Follador; Claudio Avellini; Gianpiero Fasola
Journal:  Clin Pract       Date:  2011-05-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.